Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775957 · ClinicalTrials.gov registry record
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 35
- Enrollment target
NCT00775957 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 35 participants.
The verdict
NCT00775957 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
Interventions
- PROCEDURE FLT-PET scan
- PROCEDURE FDG-PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00775957
The ClinicalTrials.gov registry entry for NCT00775957 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FLT-PET scan is the first listed.
NCT00775957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00775957 about?
NCT00775957 is a clinical study titled "Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma". A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
What is the current status of trial NCT00775957?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2008-10.
What interventions are being tested in trial NCT00775957?
The interventions under investigation include: FLT-PET scan (PROCEDURE), FDG-PET scan (PROCEDURE).
Who is sponsoring clinical trial NCT00775957?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.